NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal first quarter revenues rose 5 percent year over year, largely due to a 9 percent increase in revenues from its life sciences business.

For the three months ended Dec. 31, the company posted revenues of $3.08 billion, compared to $2.92 billion in the year-ago quarter, beating Wall Street analysts' average estimate of $3.05 billion. On a currency-neutral basis, revenues grew 4 percent, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.